Julie Refardt
0000-0002-3040-4685
8 papers found
Refreshing results…
Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia
Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Effect of Arginine on the Hypothalamic–Pituitary–Adrenal Axis in Individuals With and Without Vasopressin Deficiency
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis
Cosyntropin testing does not predict response to glucocorticoids in community‐acquired pneumonia in a randomized controlled trial
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis
Missing publications? Search for publications with a matching author name.